Volumes : Issues : Articles

Cancer Watch 2000
Cancer Watch 2001
Cancer Watch 2002
Cancer Watch 2003
Cancer Watch 2004
Cancer Watch 2005
Cancer Watch 2006
Cancer Watch 2007
Cancer Watch 2008
Cancer Watch 2009
Cancer Watch 2010
Cancer Watch 2011
Cancer Watch 2012

CW June 2002

Volume 11
Issue Number 6
June 2002
ISSN 10593802

Xeloda Plus Taxotere Improves Survival of Breast Cancer Patients

Capecitabine (Xeloda), a novel prodrug, in combination with docetaxel (Taxotere) significantly improves survival for women with metastatic breast cancer who were previously treated with anthracycline as compared to docetaxel alone.
Go to Previous Page
Go to Next Page

Source & Additional Reading

O?Shaughnessy et al., Journal of Clinical Oncology, June 15.

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details.

Download Complete Issue CW June 2002

Purchase Downloadable Full-text PDF of Complete Issue: $20.00

<< Go Back to CW June 2002